MEDIGENE AG |
Market Closed -
Other stock markets
|
After market 02:38:17 pm | |||
| 1.295 EUR | -6.83% |
|
1.298 | +0.23% |
| 12:46pm | Medigene, BioNTech Extend Cancer Immunotherapy Partnership | MT |
| May. 15 | Medigene AG Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 37.08M | - | |||||
| 115B | ||||||
| 107B | ||||||
| 22.31B | - | |||||
| 21.6B | - | |||||
| 18.23B | - |
- Stock Market
- Equities
- MDG1 Stock
- Charts Medigene AG
- Sector Chart
